⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1133394 | 0.97 | ALDH1A1 (0.30) | — | |
| SCHEMBL8511095 | 0.93 | ALDH1A1 (0.35) | — | |
| SCHEMBL7466861 | 0.93 | ALDH1A1 (0.35) | — | |
| SCHEMBL9644556 | 0.93 | ALDH1A1 (0.35) | — | |
| SCHEMBL8653745 | 0.93 | ALDH1A1 (0.35) | — | |
| SCHEMBL1723980 | 0.93 | — | — | |
| SCHEMBL6359428 | 0.93 | — | — | |
| SCHEMBL1396932 | 0.90 | — | — | |
| SCHEMBL23451893 | 0.87 | — | — | |
| SCHEMBL1629382 | 0.86 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1261610-A2 | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION | Bristol-Myers Squibb Pharma Company (US) | 2002-12-04 | — | — | EP | claimed |
| US-20020055501-A1 | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-05-09 | — | — | US | claimed |
| WO-2001060826-A2 | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| US-9459533-B2 | Polymer composition, photoresist comprising the polymer composition, and coated article comprising the photoresist | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-10-04 | — | — | US | disclosed |
| WO-2016034556-A2 | OPTO-ELECTRONIC DEVICE CONTAINING EMITTER COMPOUND WITH HIGH QUANTUM YIELD AND SOLUBILITY | CYNORA GMBH (DE) | 2016-03-10 | — | — | WO | disclosed |
| EP-2993176-A1 | METAL (I) COMPLEXES FOR IMPROVED CONDUCTIVITY | cynora GmbH (DE) | 2016-03-09 | — | — | EP | disclosed |
| US-20140004464-A1 | POLYMER COMPOSITION, PHOTORESIST COMPRISING THE POLYMER COMPOSITION, AND COATED ARTICLE COMPRISING THE PHOTORESIST | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-01-02 | — | — | US | disclosed |
| US-20040063764-A1 | Halogen compounds having thrombopoietin receptor agonism | SHIONOGI & CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1354880-A1 | HALOGEN COMPOUNDS HAVING THROMBOPOIETIN RECEPTOR AGONISM | SHIONOGI & CO., LTD. (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-6525044-B2 | Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome. | BRISTOL-MYERS SQUIBB COMPANY | 2003-02-25 | — | — | US | disclosed |
| EP-1261610-A2 | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION | Bristol-Myers Squibb Pharma Company (US) | 2002-12-04 | — | — | EP | disclosed |
| US-20020055501-A1 | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-05-09 | — | — | US | disclosed |
| WO-2001060826-A2 | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-08-23 | — | — | WO | disclosed |
| US-4767796-A | STORAGE STABLE LIQUID OF LIQUEFIED METHYLENEBIS(PHENYL ISOCYANATE) AND A CYCLOALKANE DIOL, FOR POLYURETHANES | THE DOW CHEMICAL COMPANY (US) | 1988-08-30 | — | — | US | disclosed |
| EP-0114028-A2 | Colour-photographic recording material | CIBA-GEIGY AG (CH) | 1984-07-25 | — | — | EP | disclosed |